Welsh Policies and Consultations

The RPS Wales team produces policies and consultation responses in Wales, and contributes to GB-wide policies and consultations where they are relevant in Wales.

Open Consultations in Wales

There are no consultations currently open in Wales

If you would like to provide comments on any of these consultations, please email us at [email protected]

RPS GB Policies Relevant to Wales

If you would like to provide comments on any of these consultations, please email us at [email protected]

Recent Policies

• Multidisciplinary Teams (MDT) in General Practice 
• Palliative Care
• Long Term Conditions 
• Care Homes 
• Cluster working 

Commissioned Work

The RPS in Wales in 2018 were commissioned by the Welsh Pharmaceutical Committee to project manage and author a long term vision for pharmacy in Wales. The result is Pharmacy: Delivering a Healthier Wales.

Recent consultations

April 2024

Consultation on draft Standards for Chief Pharmacists | GPhC

March 2024

Proposals to expand access to take-home naloxone supplies | GOV.UK

Development of the Mental Health Standards of Care (Wales) Bill | Welsh Parliament

February 2024

Pharmacy Supervision Consultation | GOV.UK

All Wales guidance for penicillin allergy de-labelling | AWTTC

August 2023

• Proposals to increase fees consultation | GPhC 

July 2022

• RPS response to AWTTC Work Programme 2022-23 Consultation Pro-forma | AWTTC
• RPS response to Multi-professional Clinical Framework Consultation | NHS Wales

June 2022

• RPS response to consultations on Impact of the waiting times backlog on people in Wales who are waiting for diagnosis or treatment | Welsh HSCC
• RPS response to consultation on Vitamin D call for evidence

May 2022

• RPS response to consultation pro-forma for all Wales Guidance for Prescribing Intervals | AWTTC
• RPS response to consultation on Aquiette (oxybutynin hydrochloride) POM to P

April 2022

• RPS response to UK COVID-19 Inquiry: Have your say  | COVID Enquiry
• RPS response to consultation on Healthcare regulation: deciding when statutory regulation is appropriate | DHSC

March 2022

• RPS response to consultation on Developing a Strategic Mental Health Workforce Plan for Health and Social Care | HEIW
• RPS response to Disability Workforce Reporting consultation | HM Government
• RPS response to proposals for legislative change for Clinical Trials | MHRA
• Amendments to the Poisons Act 1972 Consultation | RPS

February 2022 

• RPS Wales response to the Health and Social Care Committee inquiry into mental health inequalities | Welsh Government
• RPS response to consultation on Call for Signatories – supervised Overdose Prevention Centres | FPHC
• RPS response to Care home medicines optimisation toolkit consultation | AWTTC
• RPS response to the General Pharmaceutical Council consultation on remote hearings consultation | GPhC
• RPS Wales response to Tobacco control strategy for Wales and delivery plan consultation  | Welsh Government

January 2022

• RPS response to Inquiry regarding hospital discharge and its impact on patient flow | Welsh Parliament

September 2021

• Consultation Response from RPS Wales to HEIW Medicines Administration Units  | HEIW
• Comment on All Wales Chronic Pain Resources  | AWTTC NHS Wales

August 2021

• All Adult Wales Asthma Management and Prescribing Guideline | AWTTC
• All Wales COPD Management and Prescribing Guideline | AWTTC

July 2021

• Consultation on the equality, diversity and inclusion strategy | GPhC
• Welsh Government consultation on a Race Equality Action Plan for Wales 

June 2021

• Consultation on how we set fees for pharmacy professionals | GPhC
• Nuromol Dual Action Pain Relief 200mg/500mg tablets (ibuprofen/paracetamol) consultation | MHRA
• Regulating healthcare professionals, protecting the public | DHSC
• Review of Tramadol Resources | AWTTC

May 2021

• Private coronavirus (COVID 19) testing validation | DHSC
• Type 1 diabetes in adults: diagnosis and management (update) | NICE
• Indicators for antidepressant prescribing and dementia | NICE

April 2021

• Reviewing our process for health technology evaluation | NICE
• Guideline on weight management | NICE
• Call for Evidence – Barriers to research for controlled drugs (excluding synthetic cannabinoids) | ACMD

March 2021

• Welsh Parliament Health, Social Care and Sport Committee inquiry into the Covid-19 outbreak on health and social care in Wales: Post-Covid Syndrome | Welsh Parliament

February 2021

• Community Diagnostics | Welsh Government
• Termination of Pregnancy arrangements in Wales | Welsh Government
• Initial Clinical Management of Adult Smokers in Secondary Care | AWTTC

November 2020

• A digital special health authority for Wales | Welsh Government

October 2020

• Welsh Language Standards for healthcare regulators and the Professional Standards Authority  | Welsh Government
• Shared Care Prescribing and Monitoring Guidance  | AWTTC